Theratechnologies Presents New Tesamorelin Data Demonstrating Improvement of Metabolic Syndrome ...

Presentation at Conference on Retroviruses and Opportunistic Infections (CROI) demonstrates association between excess visceral abdominal fat (EVAF) reduction and decreased prevalence of metabolic syndrome with tesamorelin treatmentData provide further evidence

Related Keywords

Montreal , Quebec , Canada , Elif Mcdonald , Julie Schneiderman , Roger Bedimo , University Of Texas Southwestern Medical Center , National Cholesterol Education Program , Theratechnologies Inc , International Diabetes Federation , Communications Corporate Affairs , Opportunistic Infections , Texas Southwestern Medical , National , National News ,